J. Perinat. Med. 6 (1978) [2, 3, 13] . It has been well documented that the maximal effect of meperidine occurs within 30-60 minutes after administration to the mother but that a neonatal depression may be recognized äs late äs 2-4 hours after administration of meperidine [2, 9, 12] . Opiate antagonists have frequently been recommended for the prophylaxis of postpartum adaption disturbances caused by Opiates. Basically two kinds of antagonists exist [9] : Agonistantagonists such äs nalorphine and levallorphan on the one hand and pure antagonists such äs naloxone on the other hand. Agonist-antagonists may cause a respiratory depression if they are over-dosed or if there is no opiate present on the receptor site. This effect is not present with naloxone. If naloxone is given to the mother 5-15 minutes before birth or is injected immediately postpartum into the umbilical vein, the agent wül prevent a postpartum neonatal respiratory depression [4, 5, 6, 7, 8, 9, 10, 14] , Various doses have been re-1 Narcan®, Endo-JUb, Inc.
commended for the umbilical vein injection [4, 6, 7, 8, 9, 11] . The purpose of this study was to investigate the influence of various naloxone doses on the postpartum course of neonatal blood gases and acidbase Status following injection into the umbilical vein.
l Experimental design and experimental groups
The study was carried out in two parts. Part I refers to 40 newborns randomly distributed into four groups. The newborns of Group I/l were the controls; they had the usual postpartum care and did not receive naloxone. N'eonates in Group 1/2 received 0.02 mg/kg naloxone into the umbilical vein, infants in Group 1/3 received 0.03 mg/kg and those in Group 1/4 0.04 mg/kg of naloxone. In Part II there were 30 newborns randomly distributed into three groups. The infants in Group II/l received immediately postpartum an umbilical venous injection of placebo, those in Group II/2 0.04 mg/kg naloxone, and those in Group H/3 0.04 mg naloxone. Part II of this study was designed äs a double blind study where examiner and follow-up examiner were not informed about the agent or the dose. Placebo and the varying amounts of naloxone doses were distributed in equal amounts of volume and thus indistinguishable. The mothers of all newborns received at a cervical dilation of 3-4 cm 0.1 mg/kg of dehydrobenzperidol and 0.4 mg/kg of meperidine intravenously. The usual clinical variables and blood gases were recorded 30 minutes after the administration. When labor pain increased again, another dose of 0.4 mg/kg of meperidine was injected intravenously at the mothcr's request. One, five and ten minutes after birth the Apgar Status of the newborn, blood gas and acid-base examinations were performed. Blood gas and acid-base Status was repeated at 30, 60 and 120 minutes after birth. The blood samples were obtained from the hyperemized heel. pH, PC0 2 , base-excess Standard bicarbonate, and P0 2 were obtained with the ASTRUP apparatus and the SIGGAARD-ANDERSON nomogram.
Results

PartI
The maternal age was between 25. 5 (Fig. 1) . The same was true for the neonatal PCO 2 values (Fig. 2) . However, a statistically significant difference was seen for the ; difference of the PC0 2 values from the base line Value at one minute (Δ PC0 2 ) 30 and 60 minutes after birth in groups 2 and 4 (0.02 and 0.04 mg/kg). In the two naloxone groups the PCO 2 values decreased more markedly when compared to the control group at 30 and 60 minutes after birth (Fig. 3) . Neither the absolute nor the difference values to the base line for P0 2 (Δ P0 2 ) were significantly different between the control group and the naloxone groups (Fig. 4) . Thus, it was documented that under the conditions of the experiment (dose of meperidine, interval between meperidine and birth, etc) there were no significant differences between the controls and experimental groups: however, the decrease in the PC0 2 values in naloxone groups 1/2 and 1/4 were more marked than that in the control group. In order to verify this effect in a double blind experiment a new control group and a naloxone group with a dose of 0.04 mg/kg were compared with each other. Added to this experimental group were ten newborns who received only 0.04 mg of naloxone.
Part II
The age of the mothers in Part II was between 25.7 and 26.6 years, they weighed between 70.1 and 75.6 kg. Dehydrobenzperidol was given in total doses between 7.0 and 7.6 mg; the todal dose of meperidine was between 32.4 and 61.5 mg. The duration of labor was between 81.7 and 186.7 minutes, the administration of meperidine between 0.39 and 0.7 mg/minute or 0.33 to 0.56 mg/kg/ hour respectively. The time between the last dose of meperidine and birth was 54.5 to 69.7 minutes. The newborns in Part II of the study weighed between 3247 and 3338 grams. Maternal pH, PC0 2 , P0 2 and base-excess values in all three study groups of Part II were nearly identical and there were no statistically significant differences.
The pH values of the newborn were not statistically different in all three groups (Fig. 5 ). The same was true for the absolute PC0 2 values (Fig. 6 ). While the PC0 2 differences in comparison to the base line value were higher in both naloxone groups than the control group, this was statistically significant only for ten minutes after birth (P < 0.05); the differences were not significant for the other intervals (Fig. 7) . PO 2 and base-excess values did not differ in either the absolute values or the differences to the base line (Fig. 8 ). [7, 8, 14] record the total dose of meperidine administered and its level in the umbilical vein at the time of delivery but these authors did not measure capillary blood gas values and acidbase Status while recording alveolar PCO 2 and CO 2 production. The meperidine doses in our study are relatively low. According to the "Reisensburg recommendations" [1] intravenous application of low doses of meperidine establishes a base line sedation and analgesia; the patients at their request received additional low doses of analgesics intravenously.
Thus, the results of these various investigations differ in methodology and the dose of meperidine. Therefore, the basic Situation of the experiment, namely, the degree of the postpartum respiratory depression of the newborn, differ in those studies.
The primary reason for the differences should be the variously high doses of meperidine and the varyinglong intervals between last dose of meperidine and delivery. Possibly the routes of administrationin tramuscularly vs intravenously-are also important.
Thus, it may be assumed in those studies in which a marked and statistically significant respiratory effect was demonstrated, that there was a notable respiratory depression of the newbom. In the group responding poorly only a minor degree of respiratory depression of the newborn may have been present. Thus, those newborns in which there was no effect should be classified äs being depressed not due to opiates. They demonstrate that naloxone in itself does not cause respiratory depression even if the agent is overdosed or there isno meperidine on the receptor site. In summary, our study and those, previously published allow the following conclusions:
1. The use of naloxone in the newborn in the postpartum periodhas no negative effects (in contrast to nalorphin and levallorphan) 2. In the presence of respiratory depression there is a significantly faster CO 2 elimination (higher APC0 2 values) than without the use of naloxone. 3. An optimal dose has not been established in this study. While 0.04 mg/kg had a stronger effect in the first part of the experiment than 0.02 mg and 0.03 mg/kg, but it was also seen that 0.02 mg/kg was more effective than 0.03 mg/kg.
The second part of the study demonstrated that the administration of 0.04 mg/kg is äs much or äs little effective äs is the injection of 0.04 mg äs a total dose. For clinical purposes the conclusion may be drawn that if an opiate-related respiratory depression of the newborn issuspectedit may be treated without risk and with a dependable effect by the administration of naloxone.
Summary
The influence of postpartum injections of various doses of naloxone on the blood gases and acid base Status of 70 newborns was investigated. In Part I of the experiment groups of 10 newborns each received 0.02, 0.03, or 0.04 mg/kg naloxone through the umbilical vein immediately after birth; there was a control group of 10 neonates. Part II of the experiment comprised three groups of ten newborns each received immediately after birth into their umbilical veins an injection of placebo (group 1), 0.04 mg/ kg naloxone (group 2), or 0.04 mg naloxone (group 3). The second experiment was conducted äs a double blind study. All mothers received during labor 0.1 mg/kg dehydrobenzperidol and 0.4 mg/kg meperidine intravenously when the cervical dilatation was 3-4 cm. Additionally, 0.4 mg/kg of meperidine was given again if labor pain increased. The mean duration of labor was between 81.7 and 186.7 minutes; the time between the last dose of meperidine and birth was between 54.4 and 96 minutes. The mean dose of meperidine was between 0.39 and 0.7 mg/minute or 0.33 to 0.56 mg/kg hour respectively. The course of the neonatal pH values PCÜ2 and PÜ2 up to two hours after birth in the first part of the experiment was not different. However, the PC(>2, i.e. the difference of the PCO2 values at the various measuring intervals from the base line value l minute after birth for groups 2 and 4 was statistically significantly lower at 30 and 60 minutes than the control group or group 3.
The experimental design of a double blind study in Part II of these studies again showed no differences in regard to pH, PCO 2 , PO 2 , or base-excess values. While the PCO 2 differences from the base line value were larger than the control group, this was significant only for ten minutes after birth. Keywords: acid-base Status, analgesia, antagonist, birth, blood gases, dehydrobenzperidol, naloxone, neonate, meperidine, respiratory depression.
Zusammenfassung:
Klinische Untersuchungen zum Einfluß unterschiedlicher Naloxon-Dosen auf das Neugeborene p o st partum. An insgesamt 70 Neugeborenen wurde der Einfluß der postpartalen Injektion unterschiedlicher Dosen von Naloxon auf die Blutgase und die Parameter des Säuren-Basen-Haushaltes untersucht. In Teil I erhielten je 10 Neugeborene 0,02 bzw. 0,03 bzw. 0,04 mg/kg Naloxon unmittelbar postpartal in die Nabelvene injiziert, 10 Neugeborene dienten als Kontrollgruppe. Teil II der Untersuchungen bezog sich auf 30 Neugeborene, die wiederum randomisiert auf 3 Gruppen verteilt waren. Die Neu-, geborenen der Gruppe l erhielten unmittelbar postpartal ' Placebo in die Nabelvene injiziert, die Neugeborenen der Gruppe 2 0,04 mg/kg Naloxon und die Neugeborenen der Gruppe 3 0,04 mg Naloxon. Teil II der Untersuchungen war als Doppelblindversuch angelegt. Alle Mütter hatten unter der Geburt initial bei einer Muttermundsweite von 3-4 cm 0,1 mg/kg Dehydrobenzperidol und 0,4 mg/kg Dolantin intravenös injiziert erhalten. Sobald die Wehenschmerzen wieder zunahmen, wurden jeweils weitere 0,4 mg/kg Dolantin intravenös nachinjiziert. Die Geburtsdauer betrug durchschnittlich zwischen 81,7 und 186,7 min, die Zeit zwischen der letzten DolantinApplikation und der Geburt zwischen 54,4 und 96 min. Der intravenöse Dolantin-Verbrauch lag im Mittel zwischen 0,39 und 0,7 mg/min bzw. 0,33-0,56 mg/kg/h. Der bis zu 2 h nach der Geburt verfolgte neonatale pHWertverlauf ließ innerhalb des L Teils der Untersuchungen keinen statistisch relevanten Unterschied erkennen. Das gleiche traf auf die PCO2-Werte und die PÜ2-Werte zu.
Wurde jedoch PCO 2 -d. h. die Differenz der PCO 2 -Werte zu den jeweiligen Meßzeitpunkten gegenüber dem Ausgangswert l min nach der Geburt -gebildet, so ergab sich in den Gruppen 2 und 4 (0,02-0,04 mg/kg) ein statistisch signifikanter Unterschied gegenüber der Kontrollgruppe und der Gruppe 3; die PCO2-Werte dieser beiden Gruppen waren 30 und 60 min nach der Geburt ausgeprägter abgefallen als die PCCVWerte der übrigen Gruppen. Auch unter den Bedingungen des DoppelblindversuchesTeil Ii der Untersuchungen -zeigten sich im pH-Wertverlauf, im Verlauf der PC(>2-, PC>2-und Base-ExcessWerte keine statistisch relevanten Unterschiede zwischen den Gruppen. Wenn auch die PCO2-Differenzen wiederum gegenüber dem Ausgangswert in beiden Naxolon-Gruppen erheblich größer waren als in der Kontrollgruppe, so ließ sich doch ein statistisch relevanter Unterschied lediglich 10 min nach der Geburt auf dem 5%-Niveau nachweisen ( PC0 2 
